Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
life sciences
national blog main
new york blog main
new york top stories
3
×
boston blog main
boston top stories
cancer
cancer drugs
deals
fda
national top stories
new york
san francisco blog main
san francisco top stories
takeda pharmaceutical
abbvie
agios pharmaceuticals
alex gorsky
allergan aesthetics
alzheimer's disease
amgen
ashley mcevoy
astrazeneca
athira pharma
attralus
auris health
biontech
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
clinical trials
covid-19
cullinan oncology
cystic fibrosis
daniel o'day
david e. shaw
What
company’s
3
×
buy
pipeline
acquiring
acquisitions
auris
biggest
billion
bio
build
builds
cash
ceo
course
daniel
deal
debut
developer
development
discover
drug
dyne’s
experimental
gilead
growing
handiwork
health
helped
internal
ipo
johnson
landscape
medical
medicines
microbiome
moves
openly
o’day
plans
robotics
Language
unset
Current search:
company’s
×
photo
×
" new york top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B